China National Pharmaceutical Group: The net profit for the first half of 2025 was 672 million yuan, a year-on-year decrease of 6.46%.

Guoyao Modern announced that in the first half of 2025, its operating income reached 4.878 billion yuan, a year-on-year decrease of 18.16%; net profit was 672 million yuan, a year-on-year decrease of 6.46%. Due to market supply and demand factors, the sales volume and prices of some penicillin raw materials and intermediates of the company decreased year-on-year; in the formulation business segment, the sales revenue decreased year-on-year due to factors such as drug centralized procurement and reduced end-user demand affecting certain cephalosporin, hormone, and nerve class products.